Listen and Learn

Periodically, Support Connection offers educational programs by webinar or toll-free teleconference. On this page you’ll find audio recordings, slides and transcripts from past programs. If you have any questions, feel free to call us at 914-962-6402 or toll-free 800-532-4290.


Annual Webinar/Teleconference for Women with Ovarian Cancer: Advances in Ovarian Cancer Treatment
Sept. 19, 2017

Speaker: Thomas J. Herzog, MD

Dr. Herzog is Deputy Director of both The Barrett Cancer Center & The University of Cincinnati Cancer Institute. He is also Vice-Chair of Quality and Safety for Obstetrics and Gynecology, University of Cincinnati College of Medicine. From 2004 to 2014 he was the Director of Gynecologic Oncology and the Physicians & Surgeons Endowed Professor of Clinical Gynecology and Obstetrics at Columbia University. He also was the Fellowship Director in Gynecologic Oncology for Columbia & Cornell Universities and New York Presbyterian hospitals.

Prior to 2004, Dr. Herzog was as an Associate Professor, and the Director of the Fellowship Training Program at Washington University in St. Louis. He has served as a Principal Investigator in a number of GOG trials with a special emphasis in ovarian and endometrial cancers.

Dr. Herzog has authored/co-authored over 270 peer-reviewed articles and lectures extensively nationally and internationally. He serves or has served on the editorial boards of Gynecologic Oncology, Obstetrics and Gynecology International, Hematology Oncology Times, and others. He is Co-Editor–in chief of Gynecologic Oncology Research to Practice. Dr. Herzog has been on the leadership council of the Society of Gynecologic Oncology, the Foundation for Women’s Cancer, Board of Governors for the American College of Surgeons. In 2013, he was elected to the Board of the American Board of Obstetrics and Gynecology, and in 2014 to Council for the International Gynecologic Cancer Society. In 2015 he was elected to the  Board of Director of Gynecologic Oncology Group Foundation. 

Topics:

  • The latest info on the development of drugs for advanced ovarian cancer
  • Other novel chemotherapeutic agents in development
  • Advances in immunotherapy
  • PARP Inhibitors
  • The role of molecular profiling
  • Info from the Cancer Institute Survivorship Survey
  • What do patients want?

Audio and slides from Support Connection’s Ovarian Cancer Webinar
Recorded on Sept. 19, 2017:

Download written transcript


Webinar/Teleconference: The Road Forward: Navigating Life After Cancer Treatments
February 7, 2017

Although finishing your cancer treatments (surgery, chemo or radiation) is a milestone to be celebrated, it can also bring anxiety, fear and uncertainty. The completion of treatment marks the start of adjusting to new and challenging physical and emotional changes. This webinar addresses how you can take charge and navigate this transition to the new normal of cancer survivorship.

Topics include:

  • Recommendations for surveillance: Which tests and exams do I need? Who do I need to follow up with? What’s coming in the future regarding primary care vs. medical oncology?
  • Late and long term treatment effects: Things you must know about such as lymphedema; cardiotoxicity; cognitive issues; bone health; pain.
  • Psychosocial issues: Body image; depression or anxiety; fatigue. They are not all in your head!
  • Mind & body wellness: The connections between the two.
  • Other concerns: Sexual health, fertility and menopause; your ongoing treatment plan for long term health and wellness through nutrition, physical fitness, etc.

Speaker: Mary Greco, MSN, FNP-BC, CBCN, CN-BP: Mary is a certified nurse practitioner with 30 years’ experience in the area of Breast Disease. She is an Oncology Breast Care Nurse and a Breast Cancer Nurse Navigator, certified by the American Nurses Credentialing Center, the Oncology Nurses Society, and the National Accrediting Program for Breast Centers. Mary has worked in clinical practices and as a clinical research assistant in the fields of breast cancer and cell mediated immunity. She has been a nurse trainer for the NYS Dept. of Health Cancer Screening Program, has volunteered for the American Cancer Society for the promotion of breast health education, and belongs to multiple nurse and breast specialty organizations. At Northern Westchester Hospital, Mary serves as clinical coordinator for the Breast Institute.

Audio and slides from Support Connection’s Webinar “The Road Forward: Navigating Life After Cancer Treatments”
Recorded on Feb. 7, 2017

Download written transcript.


Webinar/Teleconference: Nutrition for Breast and Ovarian Cancer Care
October 26,2016

Speaker: Francine Blinten, MS, CCN, CNS. Francine Blinten is a Clinical Nutritionist who has worked extensively with patients through all phases of cancer diagnosis, treatment and post-treatment. She holds an MS from the Nutrition Institute at Bridgeport University, and is board certified by the International and American Association of Clinical Nutritionists and the Certification Board of Nutrition Specialists.

For 5 years, Francine was on staff at the Boyd Center for Integrative Health, led by Dr. Barry Boyd, a leading oncologist in Greenwich, CT. She helped patients use diet and lifestyle to minimize treatment side effects and reduce risk of recurrence. Since 2012 she has been a consulting nutritionist for the Connecticut Mental Health Center, a partnership between Yale University School of Medicine and the State of Connecticut. Francine also works with cancer patients in her private practice, monitoring metabolic biomarkers to avoid secondary illness and late effects of cancer treatment. In addition, she assists clients with disease prevention, weight management and food allergies or sensitivities.

Topics include:

  • What to eat at various phases of treatment: Managing side effects during active treatment ~ Nutrition after treatment, caring for the rest of you ~ Common nutritional deficiencies.
  • Facts and Myths: What is the science behind: Sugar, does it feed cancer? ~ Alkaline diets: Am I too acidic? ~ Must I juice and/or cleanse? ~ Specific diet approaches such as: Vegan, Paleo, Gluten Free.
  • Supplements: What role if any do supplements play? ~ Should I take a multivitamin? ~ Which supplements are helpful? ~ Can they do harm?

Audio and slides from Support Connection’s Webinar “Nutrition for Breast and Ovarian Cancer Care”
Recorded on Oct. 26, 2016.

Download written transcript.


Annual Webinar/Teleconference for Women with Ovarian Cancer:
Clinical Trials and Ovarian Cancer Treatment
Sept. 15, 2016

Speaker: Stephanie Blank, MD. Dr. Blank is a Gynecologic Oncologist at the NYU Clinical Cancer Center, and a Principal Investigator in numerous cancer research studies. Her research interests include targeted therapeutics and novel agents, fertility preservation in women with cancer, and cancer screening and prevention, with a focus on translational studies.

Dr. Blank completed her residency in Obstetrics and Gynecology at The New York Hospital-Cornell Medical Center and her fellowship in Gynecologic Oncology at the University of Pennsylvania Medical Center. She is an Associate Professor in Obstetrics and Gynecology in the Division of Gynecologic Oncology at the NYU School of Medicine, where she also serves as Gynecologic Oncology Fellowship Director, and Associate Division Director of Gynecologic Oncology. Dr. Blank is a full member of the Society of Gynecologic Oncologists and the American Society of Clinical Oncology.

 Topics:

  • Myths and realities: What clinical trials are, and what they aren’t
  • When to consider clinical trials
  • How to find clinical trials you’re eligible for
  • How to approach your doctor about participating in a clinical trial regardless of where the trial is being conducted
  • Targeted therapies
  • The role of genetics
  • What’s on the horizon

Audio and slides from Support Connection’s Ovarian Cancer Webinar
Recorded on Sept. 15, 2016:

Download written transcript


Annual Webinar/Teleconference for Women with Ovarian Cancer:
Molecular Profiling As A Guide to Ovarian Cancer Treatment
Sept. 17, 2015

*Thank you to The HERA Women’s Cancer Foundation for their grant to support this program. 

Speaker: Laura Shawver, PhD.: Founder of the The Clearity Foundation, which helps women with recurrent and refractory ovarian cancer obtain access to molecular profiling. Dr. Shawver is a biotechnology entrepreneur with 25 years of experience in cancer research and drug development. She has spent more than two decades studying cancer-causing proteins. An active of the American Association for Cancer Research, she has served on Hollywood’s Stand Up 2 Cancer scientific advisory committee since its inception in 2008. In addition, Dr. Shawver is an ovarian cancer survivor, diagnosed in 2006.

Topics:

  • What is molecular profiling?
  • Why should I consider molecular profiling and when is it not right?
  • What are the potential benefits?
  • Examples of how testing has helped patients and research.
  • How does testing work: cost, process, time frame, test results?
  • What is my next step?
  • How will this information be used by me, by my doctor?
  • How can The Clearity Foundation help patients through this process?

Audio and slides from Support Connection’s Ovarian Cancer Webinar
Recorded on Sept. 17, 2015:

Download written transcript.


Webinar/Teleconference: Managing Side Effects of Ovarian Cancer Treatments
Feb. 12, 2015

Speaker: Nancy Hacker RN, BSN, OCN of Memorial Sloan Kettering Cancer Center Sleepy Hollow. Nancy is an oncology nurse whose areas of focus include the education of patients undergoing treatments for breast cancer and gynecological cancer. Her strengths include direct symptom management in relation to the side effects from chemotherapy, hormonal therapy, and radiation therapy.

Overview: The treatment of ovarian cancer with chemotherapies, targeted therapies, hormonal therapy and radiation therapies aim to eradicate cancer cells. Unfortunately while doing their work they can also cause side-effects. This program addresses the questions: What are the common side effects? How can the symptoms of side-effects, such as neuropathy and extreme fatigue, be managed to maintain quality of life during treatment and beyond? Is there need to be concerned with heart health as a result of treatments?

Support Connection, Inc.: Managing Side Effects of Ovarian Cancer Treatments
Audio and slides: Part One
Recorded on Feb. 12, 2015

Support Connection, Inc.: Managing Side Effects of Ovarian Cancer Treatments
Audio and slides: Part Two
Recorded on Feb. 12, 2015

Download written transcript.


Annual Webinar/Teleconference for Women with Ovarian Cancer
Sept. 23, 2014

*Thank you to The HERA Women’s Cancer Foundation for their grant to support this program. 

Speaker: Dr. David Spriggs, MD, Head of the Division of Solid Tumor Oncology and Winthrop Rockefeller Chair of Medical Oncology at Memorial Sloan Kettering Cancer Center. Dr. Spriggs completed residencies at Presbyterian Hospital (New York); The New York Hospital/Cornell Medical Center, and Fellowships at Harvard Medical School; Dana-Farber Cancer Institute; Brigham and Women’s Hospital. He is Board certified in Medical Oncology and Internal Medicine. In addition to the daily care of women with gynecologic cancers, runs clinical trials testing new, targeted drugs, and oversees a small research laboratory looking for answers to questions such as why certain tumors resist drug treatment and how genes can affect the development of tumors.

 Topics:

  • The latest information in the development of drugs for advanced ovarian cancer
  • Advances in immune therapy
  • Question and answer period

Please note: This was our 1st webinar, recorded with technology that was new to us. You will hear some background sounds we are unable to eliminate. You can refer to the transcript below for further details. Thank you for understanding!

Audio and slides from Support Connection’s Ovarian Cancer Webinar
Recorded on Sept. 23, 2014:

Download written transcript.


Genetic Counseling for Breast and Ovarian Cancer
Feb. 11, 2014

Speaker: Nancy Cohen, MS, Cancer Genetic Counselor at Northern Westchester Hospital, Mt. Kisco, NY. Ms. Cohen holds a Master of Science degree in Human Genetics, is certified by the American Board of Genetic Counseling, and completed the City of Hope Advanced Course in Cancer Risk Assessment.

Topics:

  • What are the implications of identifying risk for hereditary cancer, for unaffected individuals as well as those diagnosed?
  • How does genetic counseling help us understand and adapt to the medical, psychological and familial implications of genetic contributions to disease?
  • Why consider genetic counseling?
  • What should you expect when you consult with a genetic counselor?
  • How might genetic counseling impact your medical management?
  • What are the testing criteria for Hereditary Breast and Ovarian Cancer syndrome (caused by mutations in the BRCA genes)?
  • How does genetic testing affect insurance coverage?

Listen to recording


Annual Toll-Free Teleconference for Women with Ovarian Cancer
Sept. 25, 2013

Speaker: Stephanie Blank, MD, Associate Professor in Obstetrics and Gynecology in the Division of Gynecologic Oncology at NYU School of Medicine, New York, NY. Dr. Blank completed her residency in Obstetrics and Gynecology at The New York Hospital Cornell Medical Center and her fellowship in Gynecologic Oncology at the University of Pennsylvania Medical Center.

Topics:

  • Advances in treatment options in the management of recurrent disease.
  • The role and promise of clinical trials.
  • The latest information on personalized medicine.
  • Genetics and heredity pertaining to ovarian cancer.

Listen to recording

Download written transcript.


Understanding Clinical Trials for Breast and Ovarian Cancer
Feb. 7, 2013

Speakers:

Yelena Novik, M.D., Assistant Professor and the Medical Director for Clinical Trials Office at NYU Langone Medical Center, New York, NY. Dr. Novik’s specialties and expertise include medical oncology, breast cancer and melanoma.

Gwen Harding-Peets, PhD: An ovarian cancer survivor and a patient advocate. Gwen has volunteered with Support Connection, Inc., SHARE and Survivors Teaching Students. She also served as a Peer Reviewer for the Dept. of Defense’s Congressionally Directed Medical Research Program for Ovarian Cancer.

Topics:

  • What are clinical trials?
  • What are the phases of clinical trials?
  • Why are clinical trials important?
  • How is patient participation important to clinical trials?
  • How is the patient safeguarded?
  • What are the benefits and risks of participating in a clinical trial?
  • What are the barriers to participation?
  • As a patient, what is it like to participate in a clinical trial and how do you find them?

Listen to recording

Download written transcript.


Annual Toll-Free Teleconference for Women with Ovarian Cancer
Sept. 18, 2012

Speaker: Michael V. Seiden, MD, PhD,  President and CEO of Fox Chase Cancer Center, Philadelphia, PA: Dr. Seiden served as Principal Investigator for Fox Chase’s NCI-sponsored comprehensive cancer center grant, and Principal Investigator for the NCI-funded ovarian SPORE grant shared by Fox Chase and the University of Pennsylvania. Previously, he served on the faculty of the Dana Farber Cancer Institute, Harvard Medical School, and Massachusetts General Hospital where his research interests included translational research in gynecological malignancies with a focus on ovarian cancer.

Topics:

  • Evolving knowledge about different sub-sets of ovarian cancer
  • The move towards treatment based on serous, muceneous, clear cell and low-grade tumors
  • The potential for individualized therapy through molecular profiling
  • Recent reports on clinical trials e.g. Avastin, PARP inhibitors
  • “BRCAness” – i.e. traits some cancers share with those occurring in BRCA1 or BRCA2 mutation carriers.

Listen to recording

Download written transcript.

Toll Free Support

800-532-4290

Email us for support.

Click here.

Check Our Calendar

Be sure to check our calendar for more information and to download events to your personal calendar!